Cargando…

HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses

The identification of recurrent somatic mutations in genes encoding epigenetic enzymes has provided a strong rationale for the development of compounds that target the epigenome for the treatment of cancer. This notion is supported by biochemical studies demonstrating aberrant recruitment of epigene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolden, J E, Shi, W, Jankowski, K, Kan, C-Y, Cluse, L, Martin, B P, MacKenzie, K L, Smyth, G K, Johnstone, R W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734831/ https://www.ncbi.nlm.nih.gov/pubmed/23449455 http://dx.doi.org/10.1038/cddis.2013.9

Ejemplares similares

The anticancer effects of HDAC inhibitors require the immune system
por: West, Alison C, et al.
Publicado: (2014)

HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma
por: Laporte, Aimée N., et al.
Publicado: (2017)

Autophagic and Apoptotic Effects of HDAC Inhibitors on Cancer Cells
por: Rikiishi, Hidemi
Publicado: (2011)

Systematic Analysis of Time-Series Gene Expression Data on Tumor Cell-Selective Apoptotic Responses to HDAC Inhibitors
por: Qi, Yun-feng, et al.
Publicado: (2014)

The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells
por: Urwanisch, Laura, et al.
Publicado: (2023)

Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors
por: Newbold, A, et al.
Publicado: (2012)

8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1
por: Zhang, Qiting, et al.
Publicado: (2021)

Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization
por: Kan, C-Y, et al.
Publicado: (2012)

HDAC inhibitor misprocesses bantam oncomiRNA, but stimulates hid induced apoptotic pathway
por: Bhadra, Utpal, et al.
Publicado: (2015)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Increased Susceptibility and Intrinsic Apoptotic Signaling in Neurons by Induced HDAC3 Expression
por: Schmitt, Heather M., et al.
Publicado: (2021)

Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers
por: Wagner, F. F., et al.
Publicado: (2015)

HDAC inhibitors stimulate viral transcription by multiple mechanisms
por: Balakrishnan, Lata, et al.
Publicado: (2008)

HDAC Inhibitor Titration of Transcription and Axolotl Tail Regeneration
por: Voss, S. Randal, et al.
Publicado: (2021)

Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
por: Schäker‐Hübner, Linda, et al.
Publicado: (2022)

Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells
por: Singh, R K, et al.
Publicado: (2008)

Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations
por: Owen, MacKenzie L, et al.
Publicado: (2021)

Allosteric Sensitization of Pro-Apoptotic BAX
por: Pritz, Jonathan R., et al.
Publicado: (2017)

Down-regulation of a pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric cancer
por: Brasacchio, Daniella, et al.
Publicado: (2018)

HIPK2 modulates p53 activity towards pro-apoptotic transcription
por: Puca, Rosa, et al.
Publicado: (2009)

Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2021)

Persistent Inhibition of ABL Tyrosine Kinase Causes Enhanced Apoptotic Response to TRAIL and Disrupts the Pro-Apoptotic Effect of Chloroquine
por: Sridevi, Priya, et al.
Publicado: (2013)

Marinopyrrole Derivatives with Sulfide Spacers as Selective Disruptors of Mcl-1 Binding to Pro-Apoptotic Protein Bim
por: Cheng, Chunwei, et al.
Publicado: (2014)

Discovering HDAC class II selective inhibitors by multidisciplinary approach
por: Lorenzi, S, et al.
Publicado: (2011)

Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
por: Zhou, Bingyi, et al.
Publicado: (2021)

Sepsis: pro-apoptotic and anti-apoptotic signals in liver cells
por: Chatzigianni, EV, et al.
Publicado: (2002)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes
por: Nebbioso, Angela, et al.
Publicado: (2009)

Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
por: Schroeder, Frederick A., et al.
Publicado: (2016)

CHOP Pro-Apoptotic Transcriptional Program in Response to ER Stress Is Hacked by Zika Virus
por: Turpin, Jonathan, et al.
Publicado: (2021)

Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die
por: Onyeagucha, Benjamin, et al.
Publicado: (2017)

Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
por: Sugihara, K., et al.
Publicado: (2014)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021)

HDAC inhibitors in kidney development and disease
por: Brilli, Lauren L., et al.
Publicado: (2012)

Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
por: Traoré, Mohamed D. M., et al.
Publicado: (2017)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
por: Wang, Yuren, et al.
Publicado: (2017)

HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma
por: Lee, Sang Wu, et al.
Publicado: (2021)

Trapoxin A Analogue as a Selective Nanomolar Inhibitor of HDAC11
por: Ho, Thanh Tu, et al.
Publicado: (2023)

EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function
por: Bahl, Sonali, et al.
Publicado: (2021)

Bioactive lipids and the control of Bax pro-apoptotic activity
por: Mignard, V, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rsqt8dhrvlt24tti3h4hmq8dki